Original news and analysis on international IP policy
The African Union delegation to the United Nations came in outspoken numbers to a press briefing today to express unshakable support for the Ethiopian candidate to be the next head of the World Health Organization, Tedros Adhanom Ghebreyesus.
The European Union free trade agreement with Singapore cannot be concluded by the European Union alone, at least not in its current form, according to an opinion (2/2015, ECLI:EU:C:2016:992) handed down by the European Court of Justice in Luxemburg earlier today.
The WikiLeaks publication of hacking tools and malware the CIA has allegedly used continues to stir the ire and fear of those concerned about the possible risk of the US government’s backdoor access to private data. But WikiLeaks' publication of alleged CIA-created malware instructions, which the CIA has not confirmed as authentic, diverts attention away from how numerous other state-sponsored agents are aggressively seeking to steal intellectual property and other data, security experts say.
CAPE TOWN, South Africa -- The belief that intellectual property promotes foreign direct investment and international trade has brought tension in African countries’ ability to eliminate trade barriers, and to ensure local governments are able to develop policies that respond to local needs, according to an extensive new analysis.
An academic conference this month will explore issues related to innovation, research and competition in the European Union, addressing topics such as 5G, big data, patents and standards.
Two new studies published by the World Health Organization provide insight on the production of pharmaceutical products in India and China. According to the studies, China has a substantial local pharmaceutical manufacturing sector which the Chinese government is closely linking to its policy objective of universal health care. India, the main global provider of generic medicines is not pursuing a comparable focus on universal health care. India is increasingly faced with Chinese pharmaceutical sector competition, with China being its main provider of commoditized active pharmaceutical ingredients (APIs).
After prevaricating for about three years, the European Union now seems to be about to ratify a treaty lifting copyright across borders for books in special format for visually impaired people. The European Blind Union saluted the agreement as great news for millions of people with visual disabilities but warned that a provision allowing EU members to impose economic compensation on organisations representing blind persons and libraries could run counter to the benefit of the treaty.
A recent article in the journal Nature Biotechnology finds that since a key United States Supreme Court decision, the European Union and United States have diverged in their patent filings for medical diagnostics.
In a talk at the re:publica 2017 in Berlin this week, academics from the Share Lab Project presented how they relied on an unusual resource to get a measure of the algorithms of Facebook. By reading through a part of the 8000 patents registered by the company, the researchers were able to shed some light into the process of how the "Empire" turns the raw data they treat their users as into those valuable big data golden profiles that then can be marketed.
The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) has long been at the centre of global public health policy in Geneva, representing industry from around the world. Now at a critical moment of change in the policymaking machinery, a new leader, Thomas Cueni of Switzerland, has taken over. Intellectual Property Watch recently sat down with him to discuss his views and vision going forward, and discovered his intellectual pragmatism and diverse experience which promise to open an ambitious new era for the association and global health policy.
Since the passage of the America Invents Act (“AIA”) in 2011, Inter Partes Reviews (“IPRs”) before the Patent Trial and Appeal Board (“PTAB”) have assumed growing importance in patent litigation in federal district courts. Until recently, IPRs have not played a significant role in International Trade Commission (“ITC”) Section 337 investigations. While the ITC is unlikely to stay a Section 337 investigation, pending IPRs will likely have an increasing impact at the ITC, especially when an IPR proceeding reaches an advanced stage before or during the pendency of a Section 337 investigation. This article examines the limited interplay to date between IPRs and Section 337 proceedings and discusses potential implications for future investigations.
“I’m from the government and I’m here to help.” Yeah, right.
Most businesses think protecting their intellectual property is their own responsibility, and it is. But what about when your intellectual property rights are violated by an evildoer? Who are you going to call?